Concepedia

Publication | Open Access

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME<sup>®</sup>

DOIFull Paper Access

13

Citations

4

References

2020

Year

Gisle Langslet, Bernard Zinman, Christoph Wanner, Stefan Hantel, Rosa-Maria Espadero, David Fitchett, Odd Erik Johansen
Diabetes and Vascular Disease Research

Abstract

The beneficial cardiovascular effects of empagliflozin was consistent across higher and lower LDL-cholesterol levels at baseline.

References

YearCitations

Page 1